Research Recruiting Opportunities

Open Surveys

GAAPP has been collaborating with the Copenhagen Institute for Futures Studies on a new programme of work about the future of COPD prevention and management at both the practice and policy level. As well as the production of an index which will compare countries. They are also undertaking a Delphi study. Participate in the survey: https://forms.office.com/Pages/ResponsePage.aspx?id=jjvZyuMbfkev96kAQ_f4JF5B1eH4Ax1DqWqw5zY0vytUMFE0QzhYR0w0UE5WNzk0TlQxRkc3UTJVMC4u

Advisory Boards and Patient Insights

The BURDEN initiative is a research project to examine the impact of Non-Cystic Fibrosis Bronchiectasis (NCFBE) on the everyday life of people living with NCFBE and their caregivers. It is also commonly referred to as bronchiectasis (without cystic fibrosis) or just bronchiectasis. Bronchiectasis is a chronic, often progressive lung disease characterized by irreversible and abnormal widening of the bronchi and chronic symptoms.

3-4 online engagements during 2024
Looking for a COPD caregiver in Asia

Inclusion criteria:

  • Can speak basic English
  • Adult 18 years or older

Looking for patients with Respiratory Virus (RSV) experience from all over the world, except UK, Spain and China.

Inclusion criteria:

  • 60 years or older
  • RSV doctors notice

Looking for Asthma patients from Latin America and Europe

Inclusion criteria:

  • Can speak English or French for EU, Spanish for LATAM,
  • Adult 18 years or older
  • Uncontrolled asthma
  • No hospital visits in last 12 months

Looking for 5 patients globally

Inclusion criteria:

  • Adult 18 years or older
  • Can speak basic English, French, or Spanish
  • All regions

Virtual 45-minute interview
Looking for COPD patients from Malaysia, China, Saudi Arabia and Belgium

Inclusion criteria:

  • Adult 18 years or older
  • Can speak basic English (If cannot speak English, a written option will be offered)

Looking for Asthma patients from Latin America and Europe

Inclusion criteria:

  • Can speak English or French for EU, Spanish for LATAM,
  • Adult 18 years or older
  • Mild to moderate asthma
  • low to medium dose Inhaled corticosteroids (ICS) alone or in combination with other inhalers
  • exacerbation in last 12 months
  • elevated risk FeNO biomarker

What is a FeNO test? The FeNO test works by measuring NO, a colorless gas, in your breath. It is used to help diagnose inflammation in people with lung diseases – especially those with asthma – along with other tests. Learn more in GAAPP’s educational flyer!

If you are interested in participating in any of these opportunities, please contact us at info@gaapp.org and reference the opportunity name.